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ABSTRACT 28 
The obligate intracellular pathogen Chlamydia (C.) trachomatis is a globally significant cause 29 
of sexually transmitted bacterial infections and the leading etiological agent of preventable 30 
blindness. The first-row transition metal iron (Fe) plays critical roles in chlamydial cell biology 31 
and acquisition of this nutrient is essential for the survival and virulence of the pathogen. 32 
Nevertheless, how C. trachomatis acquires Fe from host cells is not well understood, as it lacks 33 
genes encoding known siderophore biosynthetic pathways, receptors for host Fe-storage 34 
proteins, and the Fe acquisition machinery common to many bacteria. Recent studies have 35 
suggested that C. trachomatis directly acquires host Fe via the ATP-binding cassette permease 36 
YtgABCD. Here, we characterised YtgA, the periplasmic solute binding protein component of 37 
the transport pathway, that has been implicated in scavenging Fe(III) ions. The structure of 38 
Fe(III)-bound YtgA was determined at 2.0 Å resolution with the bound ion coordinated via a 39 
novel geometry (N3O2). This unusual coordination suggested a highly plastic metal-binding 40 
site in YtgA capable of interacting with other cations. Biochemical analyses showed that the 41 
metal-binding site of YtgA was not restricted to interaction with only Fe(III) ions, but could 42 
bind all transition metal ions examined. However, only Mn(II), Fe(II) and Ni(II) ions bound 43 
reversibly to YtgA, with Fe being the most abundant cellular transition metal in C. trachomatis. 44 
Collectively, these findings show that YtgA is the metal-recruiting component of the 45 




YtgA; solute-binding protein; Chlamydia trachomatis; iron acquisition; ABC transporter 50 
  51 
 4 
INTRODUCTION 52 
Iron (Fe) is an essential micro-nutrient for nearly all forms of life (1-3). In prokaryotes, Fe is 53 
frequently employed as a cofactor in redox-dependent processes or in central biochemical 54 
pathways, including aerobic respiration, DNA repair, and cellular metabolism (4-6). 55 
Chlamydia (C.) trachomatis is the causative agent of the most prevalent bacterial sexually 56 
transmitted infection worldwide and the leading cause of preventable blindness (7, 8). It is 57 
estimated that more than 100 million new chlamydial infection cases are diagnosed annually 58 
worldwide (9). As an obligate intracellular pathogen, this Gram-negative bacterium invades 59 
and grows within eukaryotic cells, and scavenges nutrients from the intracellular environment 60 
of the host cells (10, 11). Analysis of the C. trachomatis genome reveals that despite its small 61 
genome of ~1 megabase pairs, C. trachomatis possesses the genes that encode a complete 62 
aerobic respiratory chain that includes sodium-motive NADH-quinone oxidoreductase, 63 
succinate dehydrogenase, and the cytochrome bd complex (12), all of which are Fe-containing 64 
proteins. This implies that Fe is required for chlamydial cellular metabolism. Additionally, 65 
functional studies have provided evidence for an Fe requirement in host cell interaction. 66 
Starvation of Fe forces C. trachomatis to enter a metabolically active, yet non-infectious 67 
reticulate body form (13), with reversion to the infectious form upon relief of Fe-restrictive 68 
conditions (14). Collectively, these data indicate that Fe acquisition is essential for C. 69 
trachomatis survival and pathogenicity.  70 
In biological systems, Fe commonly exists in two oxidative states: ferrous [Fe(II)] or 71 
ferric [Fe(III)]. Prokaryotic acquisition of Fe is predominantly facilitated by siderophores and 72 
their receptors that capture and internalise Fe(III) from the extracellular environment (15) 73 
and/or surface receptors that capture Fe-containing proteins/molecules from the host, such as 74 
transferrin, lactoferrin, and haem (16). Some bacteria are also capable of directly acquiring Fe 75 
in the ferrous form through transporters such as FeoABC from Escherichia coli K12 (17), and 76 
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YfeABC from Yersinia pestis (18). Genome sequencing has revealed that C. trachomatis does 77 
not encode protein homologs of known siderophore biosynthetic pathways or surface receptor 78 
proteins involved in scavenging host-iron storage proteins/haem, which are common 79 
components of Fe acquisition systems in other bacteria. To date, the only putative Fe 80 
acquisition system identified in C. trachomatis is YtgABCD, which is comprised of YtgA, a 81 
periplasmic solute-binding protein (SBP), and YtgBCD, a cytoplasmic membrane localised 82 
ATP-binding cassette (ABC) transporter. Sequence analyses of YtgA indicate that it shares 83 
homology with the ABC transporter SBPs involved in the recruitment of metal ions (cluster A-84 
I) and metal chelates (cluster A-II). Prior studies of YtgA have proposed that the protein is 85 
specific for Fe(III) (19). However, the amino acid composition of the presumptive metal-86 
binding site and the associated bioinorganic chemistry strongly suggest that YtgA may have 87 
the capacity to interact with other first row transition metal ions such as Mn(II), but this has 88 
remained poorly defined. 89 
In this work, we combined X-ray crystallography with differential scanning fluorimetry 90 
and metal-binding assays to elucidate the structural and metal-binding properties of C. 91 
trachomatis serovar D/UW-3/Cx YtgA. We report the first high resolution structure of the 92 
protein, determined to 2.0 Å resolution in the Fe(III)-bound state. Although YtgA shares a 93 
common fold with other members of the cluster A-I subgroup of SBPs, we show that the protein 94 
has a highly plastic metal-binding site capable of offering a range of coordination geometries. 95 
Analyses of the metal-binding properties of the YtgA revealed that it was highly permissive 96 
for interaction with a broad range of transition metal ions including Mn(II), Fe(II), Co(II), 97 
Ni(II), and Zn(II). Nevertheless, functional specificity in the YtgABCD permease most likely 98 
arises from only a subset of these metal ions [Fe(II), Mn(II) and Ni(II)] being readily released 99 
from YtgA once bound.  100 
  101 
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RESULTS  102 
YtgA belongs to a subgroup of SBPs with broad ligand specificity 103 
Comparative sequence analysis of C. trachomatis YtgA with 31 functionally characterized 104 
cluster A-I and A-II SBPs revealed that the protein clustered with a subgroup of cluster A-I 105 
SBPs that have broad ligand specificity [i.e. interaction with Mn(II), Fe(II) and/or Zn(II)] (Fig. 106 
1a). This subgroup shares sequence identities of ≥ 20% over the core protein fold (over > 200 107 
amino acids) and is distinct from the Fe-recruiting cluster A-II SBPs, which bind metal-108 
chelates, and the closely related Zn(II)-specific cluster A-I SBPs. Notably, Zn(II)-specific 109 
SBPs frequently possess an acidic amino acid enriched region that is absent from YtgA (Fig. 110 
1b) (20, 21). YtgA orthologs from other chlamydial species, namely C. muridarum, C. suis, C. 111 
psittaci, and C. pneumoniae, share sequence identities ranging from 57% to 85% (over > 300 112 
amino acids). Notably, the metal-binding site residues in YtgA orthologs are strictly conserved 113 
(Fig. 2). Taken together, these data suggest that YtgA directly interacts with the ionic form of 114 
metals and may not be restricted to binding only Fe(III) ions as previously reported (19).  115 
 116 
YtgA interacts with a broad range of divalent transition metal ions 117 
To investigate the metal binding properties of C. trachomatis YtgA, we expressed a 118 
recombinant C-terminal dodecahistidine-tagged variant without the putative Sec-type signal 119 
peptide (residues 34-326) (22). Recombinant YtgA was purified by immobilized metal affinity 120 
chromatography, the affinity tag removed, and the protein further purified by size exclusion 121 
chromatography (SEC) (Fig. 3a). SEC showed that recombinant YtgA was isolated as a single 122 
monodisperse species with a relative molecular mass of 36.2 kDa (based on molecular mass 123 
standards), which matched closely with the predicted molecular mass (36.1 kDa) of 124 
recombinant, tag-cleaved monomeric YtgA (Fig. 3b). Endogenous metals, which may have co-125 
purified, were removed by denaturation at pH 4.0 in the presence of 20 mM 126 
 7 
ethylenediaminetetraacetic acid (EDTA) prior to refolding by dialysis in 20 mM Tris-HCl, pH 127 
7.2, 200 mM NaCl. Inductively coupled plasma-mass spectrometry (ICP-MS) analysis of 128 
refolded, tag-cleaved YtgA found that it was metal-free, containing less than 0.01 mol of metal 129 
ions per mol of protein. 130 
The interaction of recombinant YtgA with metal ions was first assessed by differential 131 
scanning fluorimetry (DSF) using the environmentally sensitive probe SYPRO Orange (23). 132 
DSF was performed with a range of physiologically relevant metal ions [Mg(II), Ca(II), Mn(II), 133 
Fe(II), Fe(III), Co(II), Ni(II), Cu(II) and Zn(II)] to ascertain which metals interacted with the 134 
protein. We also examined interaction with Cd(II), as this metal has been shown to bind to a 135 
related cluster A-I SBP (23). DSF analyses revealed that metal-free YtgA had a Tm of 50.5 ± 136 
0.9 °C (Table 1, Fig. 4). Treatment with a 10-fold molar excess of Mg(II), Ca(II) or Fe(III) did 137 
not significantly alter the Tm of the protein (Table 1, Fig. 4; ΔTm ± S.D. ≤ 2 °C; P > 0.05). 138 
Modest, but significant shifts in the Tm of YtgA were observed with Mn(II), Fe(II) and Ni(II) 139 
(P < 0.001), while larger shifts (>10 °C) were observed for Co(II), Zn(II) and Cd(II) ions (P < 140 
0.001). Although interaction of Cu(II) with YtgA was tested, addition of Cu(II) resulted in 141 
precipitation of YtgA upon supplementation, thus data could not be collected. These data show 142 
that YtgA is capable of interacting with a broad range of metal ions similar to other members 143 
of the Mn/Zn/Fe clade of cluster A-I SBPs. However, these findings also contrast starkly with 144 
those reported by Miller and co-workers, who concluded that YtgA was a specific Fe(III)-145 
binding SBP (19). We speculate that the interaction with Fe(III) with YtgA in that study may 146 
be attributable to the higher ratio of metal to protein used. Consequently, we further analysed 147 
YtgA and observed a modest positive shift in the protein Tm (+6.3 °C) at higher Fe(III)-protein 148 
ratios (≥ 100-fold molar excess, Fig. 4h). This data shows that Fe(III) can bind to YtgA, 149 
although it may have a poor on-rate.  150 
 151 
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YtgA and Fe(II)  152 
To complement the DSF analyses, we directly probed the metal-binding properties of YtgA by 153 
ICP-MS. Here, in vitro metal-binding assays were conducted using metal-free YtgA and a 10-154 
fold molar excess of the transition metal ions Mn(II), Fe(II), Fe(III), Co(II), Ni(II), Zn(II) and 155 
Cd(II). ICP-MS analyses revealed that YtgA bound all metal ions with stoichiometries of ~1 156 
mol metal ion per mol of protein (Fig. 5). Thus, our data show that the metal-binding site of 157 
YtgA is capable of binding one metal ion per protein molecule and is not restricted to 158 
interaction with only Fe(III) ions. We then assessed the stability of the YtgA-metal complexes 159 
by treatment with a 100-fold molar excess of the strong chelating agent EDTA, which has 160 
affinities for transition metal ions in the range of ~10-13 to 10-25 M (24). The affinities of cluster 161 
A-I SBPs for metal ions are several orders of magnitude less and are typically in the range of 162 
~10-7 to 10-9 M (20, 25). Here, we observed that the metal ions Mn(II), Fe(II) and Ni(II) were 163 
efficaciously removed by EDTA (Fig. 5). This result contrasts starkly with Fe(III), Co(II), 164 
Zn(II) and Cd(II), which formed YtgA-metal complexes with that were essentially irreversible 165 
(extraction ≤ 15%) (Fig. 5). These ions were only extracted from YtgA by unfolding the protein 166 
in the presence of EDTA. It is a physiological requirement for transport that the bound metal 167 
ion can be readily released from the SBP to the transporter. Taken together, our data suggest 168 
that Mn(II), Fe(II) and Ni(II) are potential physiological ligands of YtgA. By contrast, although 169 
Fe(III), Co(II) and Zn(II) can bind to YtgA, the stabilities of the resultant protein-metal 170 
complexes are unlikely to permit release of the ions to the YtgBCD transporter for cytoplasmic 171 
import. 172 
To better understand the physiological context of YtgA and metal transport we 173 
performed whole cell ICP-MS on C. trachomatis infectious elementary bodies (EB). This 174 
revealed that Fe was the most abundant transition metal ion (Fig. 6) with the other metals 175 
having lower abundance, which can be summarised as: Fe > Zn > Cu > Mn > Ni. Therefore, 176 
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the cellular analyses imply that YtgA most likely facilitates Fe(II) acquisition for C. 177 
trachomatis.  178 
 179 
Structural analyses of YtgA 180 
To further our understanding of C. trachomatis YtgA, a high-resolution structure of the protein 181 
was determined by X-ray crystallography. Although crystallization of the protein with Fe(II), 182 
the presumptive physiological ligand, was attempted, oxidation to Fe(III) occurred during the 183 
crystallization process, based on the observed solution colour. The YtgA crystal diffracted to 184 
2.0 Å resolution. One molecule of YtgA was present in each asymmetrical unit. Residues 34-185 
39 and 285-286 were not modelled in the refined structure due to a lack of electron density in 186 
the corresponding regions. Crystallographic refinement statistics are summarized in Table 2.  187 
YtgA comprises two globular domains, denoted as N- and C-terminal domains, and a 188 
domain-linking helix (α6) that spans the entire molecule (Fig. 7a, b). Similar to other cluster 189 
A-I SBPs, the inter-domain helix would most likely preclude large conformational motion of 190 
either domain, as reported for S. pneumoniae PsaA (26) and Yersinia pestis YfeA (27). This is 191 
in stark contrast to the shorter, flexible inter-domain linkages present in non-metal binding 192 
SBPs, such as the amino acid-binding SBP LivJ (28, 29), that permit larger movement (up to 193 
60°) of the two domains. In YtgA, the N- and C-terminal domains both comprise five α-helices 194 
(N-terminal: α1, 2, 3, 4 and 5; C-terminal: α7, 8, 9, 10 and 11) that each flank a four-stranded 195 
β-sheet (N-terminal: β1, 2, 3, and 4; C-terminal: β5, 6, 7 and 8) at the centre (Fig. 7a, b). The 196 
metal-binding site resides at the interface between the two domains and is located 197 
approximately 10 Å beneath the molecular surface of the protein. One Fe(III) ion, with full 198 
occupancy, is present at the metal-binding site of the protein, with the two globular domains 199 
closed over this region. In related cluster A-I SBPs, such as Streptococcus pneumoniae PsaA, 200 
this conformation represents the closed, ligand-bound form of the protein and is distinct from 201 
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the open, metal-free state (30). In YtgA, the loop connecting α9 and β6 on the surface of the 202 
C-terminal domain dwells directly above the bound Fe(III) ion. Together, these features bury 203 
the metal ion and the binding-site, shielding them from the bulk solvent in the closed, metal-204 
bound state (Fig. 7c). In the binding site, the bound Fe(III) ion forms coordination interactions 205 
with the Nε2 atoms from His75, His141 and His207, and the Oδ1 and Oδ2 atoms from Asp299, 206 
with the coordination bond lengths of 2.04, 2.14, 2.21, 2.01, and 2.38 Å, respectively, thus 207 
giving a distorted N3O2 trigonal bipyramidal coordination geometry to the bound metal ion 208 
(Fig. 7d).  209 
Overall, YtgA possesses a structural fold highly conserved among cluster A-I SBPs, 210 
including Treponema pallidum Zn(II)-binding SBP TroA (31) (PDB: 1TOA), Streptococcus 211 
pyogenes Fe(II/III) SBP MtsA (32) (PDB: 3HH8), Yersinia pestis Fe/Mn(II) SBP YfeA (27) 212 
(PDB: 5UY4), Staphylococcus aureus Mn(II)-binding SBP MntC (33) (PDB: 4K3V), 213 
Staphylococcus pseudintermedius Mn(II) SBP SitA (34) (PDB: 4OXR), and S. pneumoniae 214 
Mn(II)-binding SBP PsaA (35) (PDB: 3ZTT). Superimposing the crystal structures backbones 215 
revealed low rmsd values (< 1.1 Å) between YtgA and the other SBP structures (Fig. 8a,b, 216 
Table 3), despite the low level of overall sequence identity (< 26%) between them. Notably, 217 
three of the four metal-coordinating ligands in YtgA, namely, His75, His141 and Asp299, are 218 
strictly conserved through all cluster A-I SBPs compared in this study. Interestingly, the fourth 219 
metal-coordinating position in YtgA presents a histidine residue (His207), which resembles 220 
Zn(II)-specific SBPs, such as ZnuA and AdcAII, and TroA, which has been implicated as 221 
having a physiological role in Zn(II) acquisition (Fig. 8c). By contrast, structurally 222 
characterised SBPs that favour interaction with Fe, such as MtsA and YfeA (Fig. 8d), or 223 
Mn(II), such PsaA and MntC (Fig. 8e), present an acidic residue at this location. Another 224 
distinct structural feature of YtgA is that the protein possesses five helices in each of its 225 
globular domains, as opposed to the four -helices-per-domain arrangement observed in other 226 
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cluster A-I SBPs (Fig. 8b). The extra helices (α4 in the N-terminal domain and α8 in the C-227 
terminal domain) are positioned on the same side of the molecule, relative to the domain-228 
linking helix (Fig. 8a, b). Whether these extra structural elements play a role in cargo 229 
acquisition or recognition by YtgBCD permease, remains to be determined. 230 
S. pyogenes MtsA and Yersinia pestis YfeA are among the cluster A-I SBPs that show 231 
binding preference for Fe(III) (27, 32). Comparing the metal-bound states of YtgA and MtsA 232 
shows that although a single Fe(III) ion is present in both structures and adopts a distorted 233 
trigonal bipyramidal coordination geometry, the coordinating ligands offered by the metal 234 
binding sites are distinctly different. In YtgA, the Fe(III) ion is coordinated by three N and two 235 
O atoms. By contrast, in MtsA, the bound Fe(III) ion is coordinated by two N and three O 236 
atoms. In YfeA, both the acidic residues in the metal-binding site contribute to bidentate 237 
coordination with Fe(III), resulting in a two-N, four-O (N2O4) trigonal prism geometry. 238 
Notably, the coordination environment present at the YtgA metal-binding site closely 239 
resembles that of the Zn(II)-binding SBPs and TroA (31, 36, 37). Although the coordination 240 
environment is similar, the acidic residue employs both oxygen atoms to bind Fe(III) in YtgA. 241 
This is in contrast to Zn(II)-specific SBPs, where only one oxygen atom from the carboxyl 242 
group on the acidic residue is involved in reversible Zn(II) ion coordination.  243 
 244 
  245 
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DISCUSSION 246 
Acquisition of Fe is essential for the survival and virulence of the obligate intracellular 247 
pathogen C. trachomatis. The scavenging of Fe and other crucial transition metal ions from the 248 
extra-cytoplasmic environment is most commonly facilitated in prokaryotes by cluster A-I 249 
SBPs. Iron uptake by C. trachomatis is associated with the YtgABCD permease, which has 250 
been shown to be regulated by Fe via the DtxR family regulator YtgR (38). Import of Fe was 251 
inferred to be facilitated by YtgA due to its previously reported interaction with Fe(III) (19). 252 
In this study, we have determined the first high-resolution structure of YtgA and, by combining 253 
in vitro metal binding and DSF assays, reveal that YtgA is a highly promiscuous SBP capable 254 
of interaction with a broad range of transition metal ions. These findings challenge earlier 255 
conclusions regarding the physiological ligand(s) of YtgA and the inferred specificity of the 256 
YtgABCD permease.  257 
The selective import of metals ions by ABC permeases can be ascribed to the specificity 258 
of the cluster A-I SBP component. Specificity within these proteins arises from the 259 
coordinating environments offered by the metal-binding sites. First-row transition metals 260 
utilize their 3d-orbitals to form coordination bonds with ions that carry lone pair electrons, such 261 
as sulfur, oxygen, and nitrogen. The resultant complexes adopt specific spatial geometries due 262 
to the directionality of the metal ion 3d-orbitals. Analysis of the available Zn(II)-specific SBP 263 
crystal structures reveals that Zn(II) is most frequently associated with tetrahedral (4 ligands) 264 
complexes, owing to the small ionic radius of the ion. Further, as a soft Lewis acid, Zn(II) tends 265 
to interact with soft Lewis bases (39, 40), such as nitrogens in histidines. Mn(II) and Fe(II), 266 
which in contrast have larger ionic radii, can accommodate additional ligands with less 267 
repulsion energy penalty. Coordination numbers for these metal ions are frequently 5 and 6, 268 
with trigonal bipyramidal and octahedral geometries. Mn(II) and Fe(II) are hard Lewis acids 269 
that preferentially interact with hard Lewis bases (39, 40), such as the oxygen atoms from water 270 
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or carboxylate containing amino acids. The high resolution structure of YtgA shows that the 271 
metal-binding site is defined by three histidine residues (His75, His141, His207) and one 272 
aspartic acid residue (Asp299), resembling the binding sites frequently found in Zn(II)-specific 273 
SBPs such as Salmonella ZnuA (41). However, in YtgA, the conformation of Asp299 is not 274 
restricted as it is in other cluster A-I SBPs. Consequently, it allows one or both of the oxygen 275 
atoms in its carboxylate group to contribute to metal coordination. This arrangement would 276 
permit YtgA to provide tetrahedral (N3O1: 3 nitrogen atoms from His75, His141 and His207 277 
and one oxygen atom from the monodentate interaction of Asp299), trigonal bipyramidal 278 
(N3O2: 3 nitrogen atoms from His75, His141, His207 and two oxygen atoms from the 279 
bidentate interaction of Asp299), or octahedral (N3O3: 3 nitrogen atoms from His75, His141, 280 
His207, two oxygen atoms from the bidentate interaction of Asp299 and one oxygen atom from 281 
a water molecule) metal ion coordination. The balance between the “hardness” and “softness” 282 
of the ligands can be fine-tuned by including or excluding extra coordinating oxygen atoms 283 
depending on the preference of the interacting metal ion. However, this flexible coordination 284 
geometry precludes the capacity for strict selection of only a single metal ion ligand.  285 
The flexibility of YtgA Asp299 has similarity to Asp280 of Streptococcus pneumoniae 286 
PsaA (30). In PsaA, this equivalent carboxylate residue influences metal ion selection and 287 
reversibility of the metal-PsaA complex, resulting in impacts upon metal ion transport (23, 30, 288 
35, 42). Consistent with these insights, YtgA was also shown to be highly promiscuous for 289 
interaction with a range of metal ions, despite their preference for distinct coordination 290 
geometries. Nevertheless, our analyses also revealed differences in the stabilities of the 291 
resultant YtgA-metal complexes. The metal ligands Co(II), Zn(II) and Cd(II) all form highly 292 
stable complexes with YtgA, as shown by the large Tm shifts and inability of EDTA to extract 293 
the bound metal ion. Notably, we also observed that YtgA bound Fe(III) irreversibly, rendering 294 
Fe(III) an unlikely physiological ligand. This is consistent with the previous finding that YtgA 295 
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bound Fe(III) could not be replaced by 59Fe(III) (19). Interestingly, the metal ion did not 296 
significantly shift the protein Tm at similar concentrations to the other metal ligands. We 297 
speculate that this may be due to a slow on rate; alternatively, it may reflect a solubility issue 298 
associated with the FeCl3 salt in the DSF assay. Irrespective of the precise technical basis for 299 
this issue, our data indicate that YtgA stabilization with Fe(III), Co(II), Zn(II) and Cd(II) is 300 
highly thermodynamically favourable.  301 
Successful cellular import of transition metal ions is dependent not only on their 302 
efficient binding by the SBP, but also subsequent release upon interaction with the ABC 303 
transporter. Prior studies of related cluster A-I SBPs have shown that kinetically-trapped 304 
protein-metal complexes are incapable of releasing the bound metal ions to the transporter (30, 305 
35, 42). Therefore, we propose that Fe(III), Co(II), Zn(II) and Cd(II) are not transported ligands 306 
of the YtgABCD permease. Further, these ions could potentially abrogate permease function 307 
through the formation of irreversible metal-YtgA complexes. By contrast, Mn(II), Fe(II) and/or 308 
Ni(II) are potential physiological ligands with Fe(II) the most likely ligand given the 19-fold 309 
greater abundance of Fe(II) over Mn(II) in C. trachomatis cells. The cytosolic concentrations 310 
of these metal ions within the eukaryotic host cell provide additional context for speculation 311 
(43). In the cytosol, the labile pool of Fe(II) (0.1 -1 μM) and Mn(II) (1 μM (44)) is estimated 312 
to be at least 4 orders of magnitude greater than Zn(II) (50 pM (45)), Co(II), Ni(II) and Cu(II) 313 
ions. Although the relative abundance of metal ions within the membrane-bound compartment 314 
occupied by C. trachomatis in the eukaryotic cell remains unknown, it likely reflects the 315 
cytoplasmic abundance. Thus, we infer that the lower abundance of the labile forms of 316 
competing metal ions would minimise their potential interactions with YtgA in vivo. The 317 
balance of evidence indicates that YtgA is most likely involved in Fe(II) uptake, but we cannot 318 
exclude the possibility that it also facilitates low-level Mn(II) uptake as well. Current literature 319 
suggests that Chlamydiae may be able to acquire Fe(II) via the slow-recycling pathway of 320 
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endocytosed transferrin receptor (3, 46, 47). This system is assumed to rely on the reduction of 321 
transferrin-bound Fe(III) to Fe(II) via the host ferrireductase STEAP3 (48) or possibly 322 
riboflavin (49), followed by endosome fusion with the chlamydial inclusion (46, 50, 51). 323 
Further, it has been suggested that the chlamydial inclusion may interact with both 324 
mitochondria and autophagosomes, to facilitate acquisition of essential nutrients (52, 53). 325 
Collectively, these mechanisms would allow C. trachomatis to scavenge Fe(II) from the host 326 
cytosol into the Chlamydiae inclusion environment, where it could be selectively transported 327 
by YtgABCD. 328 
Given the high degree of sequence identities amongst YtgA orthologs, our observations 329 
suggest that chlamydial SBPs employ a common metal-binding mechanism. As Chlamydiae 330 
have a strict iron-dependency, the promiscuity of YtgA may arise from the composition of the 331 
metal-binding site and the associated bioinorganic limitations in achieving selectivity for 332 
Fe(II), thereby rendering it permissive for interaction with other ions. Alternatively, it may be 333 
that the chemical environment of the Chlamydiae inclusion excludes these potential competing 334 
ions, such that there is no selective pressure for greater selectivity. Further studies on 335 
Chlamydiae inclusions and the structure-function relationships of the metal-binding sites in 336 
YtgA orthologs will resolve these questions.  337 
Collectively, our work demonstrates that C. trachomatis YtgA is a cluster A-I SBP with 338 
a new variation in the modality of metal-ion coordination (N3O2) as shown for Fe. Although 339 
YtgA has been previously reported to be a Fe(III)-specific binding protein, our findings show 340 
that YtgA interacts with a range of transition metal ions in vitro. Analysis of the stability of 341 
protein-metal complexes and whole cell metal accumulation reveal that YtgA is most likely 342 
involved in the acquisition of Fe(II), but may also recruit Mn(II) from eukaryotic cells. These 343 
findings provide new molecular insights into how C. trachomatis acquires Fe from host cells 344 
and provide a robust foundation for the development of antimicrobials targeting this crucial 345 
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import pathway. 346 
  347 
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MATERIALS AND METHODS 348 
Expression and purification of YtgA 349 
Recombinant YtgA was generated by gene synthesis of C. trachomatis ytgA serovar D/UW-350 
3/Cx (Genscript, USA), PCR amplification and ligation-independent cloning using the primers 351 
YtgA1F (5’ TGGGTGGTGGATTTCCTAACCAGCCGGCAGAT) and Ytg1R (5’ 352 
TTGGAAGTATAAATTTCCTTCCAGGACCGTGCC) to insert the gene into a C-terminal 353 
dodecahistidine tag-containing vector, pCAMcLIC01, and generate pCAMcLIC01-YtgA. 354 
Protein expression was performed in E. coli Lemo21(DE3), by growing the cells in an 355 
autoinducing TB medium (Overnight Express, Merck, USA) using UltraYield Flasks 356 
(Thomson Instrument Company, USA), for 18 h at 27 °C, on an Innova 44R shaking incubator 357 
at 215 rpm. Cells were harvested, resuspended in 20 mM 4-morpholinepropanesulfonic acid 358 
(MOPS) (pH 7.2), 200 mM NaCl, 15 mM imidazole, and 20% glycerol buffer, and disrupted 359 
at 30 kPSI by a Constant Systems cell disruptor. The soluble supernatant was then isolated by 360 
centrifugation at 4 °C for 60 min at 120,000 × g. Purification of YtgA was achieved by a Histrap 361 
HP column (GE Healthcare, UK) on an ÄKTA Purifier (GE Healthcare) using a binding buffer 362 
containing 20 mM MOPS (pH 7.8), 200 mM NaCl, 10% glycerol, and 15 mM imidazole, and 363 
an elution buffer containing 20 mM MOPS (pH 6.6), 200 mM NaCl, 10% glycerol, and 1 M 364 
imidazole. The imidazole was removed by buffer exchange on a HiPrep 26/10 Desalting 365 
column (GE Healthcare), and sample homogeneity confirmed by size exclusion 366 
chromatography on a Superdex 200 10/30 column (GE Healthcare) using an ÄKTA Purifier 367 
(GE Healthcare) prior to characterization. Thyroglobulin (669 kDa), apoferritin (443 kDa), β-368 
amylase (200 kDa), alcohol dehydrogenase (150 kDa), albumin (66 kDa) and carbonic 369 
anhydrase (29 kDa) were used as molecular weight standards on the Superdex 200 10/30 370 
column, with a blue dextran standard (2 MDa) used to determine the void volume (Sigma-371 
Aldrich, USA).  372 
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 373 
Metal-free YtgA generation and metal content analysis 374 
Recombinant YtgA had the dodecahistidine tag removed by 1 h enzymatic digestion at a ratio 375 
of 1:25 by the histidine-tagged 3C human rhinovirus protease, at a cleavage site introduced 376 
between YtgA and the tag. The protein was then reverse-purified on a HisTrap HP column (GE 377 
Healthcare), with the cleaved protein unable to bind to the column. Removal of the 378 
dodecahistidine tag was confirmed by the observed reduction in molecular mass on a 4-12% 379 
SDS-PAGE gel and confirmed by immunoblotting. Demetallated (metal-free), tag-free YtgA 380 
was prepared by dialyzing the protein (10 ml) in a 10 kDa MWCO membrane (Pierce, USA) 381 
against 4 L of sodium acetate buffer, pH 4.0, with 20 mM EDTA, at 25 °C for 24 h. The sample 382 
was then dialyzed against 4 L of 20 mM Tris-HCl, pH 7.2, 200 mM NaCl, at 4 °C for 24 h. The 383 
sample was then recovered and centrifuged at 120,000 × g for 10 min to remove any insoluble 384 
material. Demetallated, tag-free YtgA was then desalted into 20 mM MOPS (pH 7.2), 200 mM 385 
NaCl, 10% glycerol on a HiPrep 26/10 Desalting column (GE Healthcare). Metal content 386 
analysis was performed by inductively coupled plasma-mass spectrometry (ICP-MS). Three 387 
micromolar protein was heated at 95 °C for 15 min in 3.5% HNO3. The insoluble material was 388 
removed by centrifugation at 18,000 × g for 20 min, after which the samples were analysed on 389 
an Agilent 7500cx ICP-MS/MS (Adelaide Microscopy, University of Adelaide). 390 
 391 
YtgA metal binding assays 392 
Metal loading assays were performed on demetallated, tag-cleaved YtgA (20 μM) by mixing 393 
with > 10-fold molar excess (200 μM) of MnSO4, FeSO4, FeCl3, CoCl2, NiCl2, CuSO4, ZnSO4, 394 
and CdCl2 in a total volume of 2 ml into the binding assay buffer (20 mM MOPS, pH 7.2, 200 395 
mM NaCl, 10% glycerol) for 2 h at 4 °C. Metal ion stock solutions for the assays were prepared 396 
immediately prior to incubation with YtgA to minimise precipitation and, in the case of FeSO4, 397 
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oxidation of Fe(II) to Fe(III). After incubation, unbound metal was removed by buffer 398 
exchange on a PD10 column (GE Healthcare) into the binding assay buffer and the protein 399 
concentration was determined. Solutions of metal-loaded protein (1.4 – 2 μM) were prepared 400 
in 3.5% HNO3 and boiled for 15 min at 95 °C. Samples were then cooled and centrifuged for 401 
20 min at 18,000 × g. The supernatant was then analysed by ICP-MS and the protein-to-metal 402 
ratio determined. 403 
 404 
Differential scanning fluorimetry 405 
The differential scanning fluorimetry assays were performed essentially as described 406 
previously (35). Briefly, 10 μM demetallated, tag-cleaved YtgA in 20 mM MOPS, pH 7.2, 200 407 
mM NaCl, 10% glycerol, 5 × SYPRO Orange (Life Technologies) was incubated in the 408 
presence of 100 μM metal ion and then analysed on a Roche LC480 Real-Time Cycler (Roche 409 
Applied Sciences). The samples were pre-incubated for 10 min with the indicated metal ion 410 
concentration and then subjected to thermal unfolding from 37 °C to 97 °C at a heating rate of 411 
1 °C per min. Fluorescence data were also collected for buffer only, protein without metal ions, 412 
and for each of the metal ions without protein. The fluorescence data were collected by 413 
excitation at 470 nm and emission at 570 nm. After subtraction of the background fluorescence 414 
from the buffer, the first derivative of the fluorescence data was determined and analysed using 415 
Graphpad Prism to determine the inflection point of the melting transition (Tm). Data from at 416 
least three independent experiments were used to determine the mean Tm (± s.d.) of wild-type 417 
YtgA. Statistical significance of the differences in the Tm shifts were determined by a one-way 418 
ANOVA using a Tukey post-test.  419 
 420 
Phylogeny  421 
The sequences of the 32 SBPs included in this study were obtained from the NCBI with the GI 422 
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accession numbers: Bacillus anthracis MntA, GI:229264967 (54); Bacillus subtilis YcdH, 423 
GI:2415736 (55); Bacillus subtilis YclQ, GI:758317765 (56); Campylobacter jejuni ZnuA, 424 
GI:384442496 (57); Chlamydia trachomatis YtgA, GI:73811687 (58); Escherichia coli FitE, 425 
GI:190907145 (59); Escherichia coli SitA, GI:84060846 (60); Escherichia coli ZnuA, 426 
GI:298380994 (61); Haemophilus influenzae FbpA, GI:1098687 (62); Haemophilus influenza 427 
ZnuA, GI:16272089 (63); Neisseria gonorrhoeae FbpA GI:1098687 (64); Neisseria 428 
gonorrhoeae MntC, GI:59800624 (65); Pseudomonas aeruginosa ZnuA, GI:15600691 (20); 429 
Sinorhizobium meliloti SitA, GI:336034510 (66); Staphylococcus aureus HtsA, 430 
GI:537378541 (67),; Staphylococcus aureus MntC, GI:88194402 (68); Staphylococcus 431 
pseudintermedius SitA, GI:317161313 (34); Streptococcus pneumoniae AdcA, GI:116516060 432 
(69); Streptococcus pneumoniae AdcAII, GI:116515739 (69); Streptococcus pneumoniae 433 
PiuA, GI:693295764 (70); Streptococcus pneumoniae PsaA, GI:116515973 (35); 434 
Streptococcus pyogenes HtsA GI:114795192 (71); Streptococcus pyogenes MtsA, 435 
GI:383493478 (32); Streptococcus suis TroA, GI:386583456 (72); Synechocystis MntC, 436 
GI:1653002 (73); Synechocystis ZnuA, GI:38492833 (74); Treponema pallidum TroA, 437 
GI:1777933 (31, 75); Treponema pallidum ZnuA, GI:378974662 (75); Vibrio cholerae VctP, 438 
GI:469674348 (76); Yersinia pestis YfeA, GI:1245464 (77); Yersinia pestis YfuA 439 
GI:913031127 (78); and Yersinia pestis ZnuA, GI:25453364 (79). An alignment of these 440 
sequences was created using Clustal Omega and the phylogenetic tree was generated using the 441 
neighbour-joining method (80, 81). 442 
 443 
C. trachomatis growth and metal content determination 444 
Whole cell ICP-MS of the isolated C. trachomatis was performed essentially as described 445 
previously (35). C. trachomatis L2 (source ATCC strain 434/Bu) was cultured in McCoy B 446 
cells (source: ATCC CRL-1696) at a multiplicity of infection of 5, until 40 h post infection as 447 
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previously described {Huston, 2008 #3797}. The C. trachomatis cells were isolated from host 448 
cell debri after cell lysis using ultravist gradient based separation (as per previous protocol 449 
{Cunningham, 2013 #3946}).  450 
 451 
Protein crystallization and structure determination 452 
Purified recombinant, demetallated, tag-free YtgA protein was concentrated to 12 mg.mL-1 453 
using a centrifugal filter unit (MWCO 10 kDa, Millipore) for crystallization experiments. 454 
Equimolar concentration of FeCl2 was added to the protein solution prior to crystallisation. The 455 
initial hit was obtained from the PACT sparse matrix screen (82). Following optimization, 456 
diffraction-quality Fe-bound YtgA protein crystals were obtained in 22 % (w/v) polyethylene 457 
glycol (PEG) 6000, 0.2 M CaCl2, 0.01 M FeCl2 and 0.1 M MES, pH 6.0 after 7 days at 18 °C 458 
using the hanging-drop vapour diffusion method. The Fe(II) supplied in the crystallisation 459 
solution was likely oxidised to Fe(III) after 3-5 days, based on the colour change of the solution. 460 
Prior to data collection, the crystals were soaked in 25 % (v/v) glycerol for cryo-protection and 461 
then flash-cooled in liquid nitrogen. Diffraction data were collected at cryogenic temperatures 462 
from a single crystal at the Australian Synchrotron MX 1 beamline (83) at X-ray wavelength 463 
of 0.954 Å. The data was then processed using XDS (84) and Aimless, CCP4 Suite (85) and 464 
the phase information was obtained by molecular replacement by Phaser, Phenix Suite (86) 465 
using the crystal structure of pneumococcal PsaA (sequence identity 21 %, PDB: 1PSZ) (87) 466 
as the search model. The structure model was subsequently created automatically using 467 
Phenix.Autobuild (88), and refined iteratively using Phenix.Refine with manual adjustment in 468 
COOT (89). Metal ions were modelled based on their peaks in the mFO-DFC difference density 469 
map, together by consideration of the B factors with their coordination ligands, and chemical 470 
plausibility. Structure analyses were performed in PyMol (Schrödinger, LLC).  471 
 472 
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Accession Number 473 
The YtgA atomic coordinates and structure factors were deposited in the Protein Data Bank 474 
with accession number 6NSI. 475 
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TABLES  743 
Table 1. Effect of divalent cations on the melting temperature of YtgA 744 
Protein a Tm (°C) b ΔTm (°C) 
Metal-free YtgA 50.52 ± 0.87 - 
Mg(II)-YtgA 49.65 ± 2.83 -1.0 
Ca(II)-YtgA 48.97 ± 3.05 -1.0 
Mn(II)-YtgA 58.82 ± 1.51 +7.7 c 
Fe(II)-YtgA 61.94 ± 0.95 +9.8 c 
Fe(III)-YtgA 51.38 ± 0.61 +0.7 
Co(II)-YtgA 76.01 ± 1.13 +25.4 c 
Ni(II)-YtgA 63.26 ± 1.55 +12.6 c 
Cu(II)-YtgA n.d.d - 
Zn(II)-YtgA 71.59 ± 1.59 +16.6 c 
Cd(II)-YtgA 71.83 ± 0.59 +19.9 c 
 745 
a. Melting curves for cations that induce a Tm shift are shown in Fig. 4. 746 
b. Values shown represent the average and standard error of the mean from at least 3 747 
independent measurements. 748 
c. Statistically significant difference to metal-free protein Tm (one-way ANOVA with Tukey 749 
post-test). 750 
d. not determined (n.d.) 751 
  752 
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Table 2. Crystallographic data collection and refinement statistics  753 
Data Collection 
Wavelength (Å) 0.954 
Resolution range (Å)  19.08-2.00 (2.07-2.00) 
Space group C 1 2 1 
a, b, c (Å) 47.8, 61.1, 105.5 
α, β, γ (°) 90.0, 96.9, 90.0 
Completeness (%) 100.0 (99.9) 
Rmerge 0.09 (1.00) 
Rpim 0.04 (0.39) 
CC(1/2) 0.99 (0.69) 
< I / σ(I) > 16.51 (2.03) 
Multiplicity 7.3 (7.2) 
No. unique reflections 20476 (2001) 
Refinement  
Rwork/ Rfree (%)  
 
17.9/22.5 





Average B-factors (Å2)  




Bond lengths (Å) 0.01 
Bond angles (°) 0.89 
 754 
Values in parentheses correspond to the highest resolution shell. 755 
Rmerge = ∑ℎ𝑘𝑘𝑘𝑘∑𝑗𝑗|𝐼𝐼ℎ𝑘𝑘𝑘𝑘,𝑗𝑗− < 𝐼𝐼ℎ𝑘𝑘𝑘𝑘 > |/(∑ℎ𝑘𝑘𝑘𝑘∑𝑗𝑗𝐼𝐼ℎ𝑘𝑘𝑘𝑘,𝑗𝑗) 
Rpim = ∑ℎ𝑘𝑘𝑘𝑘�𝑛𝑛/(𝑛𝑛 − 1)∑𝑗𝑗|𝐼𝐼ℎ𝑘𝑘𝑘𝑘,𝑗𝑗− < 𝐼𝐼ℎ𝑘𝑘𝑘𝑘 > |/(∑ℎ𝑘𝑘𝑘𝑘∑𝑗𝑗𝐼𝐼ℎ𝑘𝑘𝑘𝑘,𝑗𝑗) 
Rwork / Rfree = ∑ℎ𝑘𝑘𝑘𝑘�𝐹𝐹ℎ𝑘𝑘𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜 −  𝐹𝐹ℎ𝑘𝑘𝑘𝑘𝑐𝑐𝑐𝑐𝑘𝑘𝑐𝑐�/(∑ℎ𝑘𝑘𝑘𝑘𝐹𝐹ℎ𝑘𝑘𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜)  
Rfree was calculated using randomly chosen 5 % fraction of data that was excluded from 
refinement. 
 756 
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Number of Cα 
aligned 
PDB ID 
T. pallidium TroA 1.00 24.2 261 1TOA 
S. pyogenes MtsA 1.15 22.6 255 3HH8 
Y. pestis YfeA 1.06 21.9 250 5UY4 
S. pseudintermedius SitA 1.34 18.7 264 4OXR 
S. pneumoniae PsaA 1.29 22.8 256 3ZTT 
E. coli ZnuA 1.85 14.7 179 2PS0 
S. aureus MntC 1.07 19.6 226 4K3V 
S. pneumoniae AdcAII 1.65 18.8 239 3CX3 
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FIGURE LEGENDS 761 
Figure 1. Phylogenetic analysis of C. trachomatis YtgA. (a) YtgA was aligned to the amino-762 
acid sequences of 31 other characterised cluster A-I and A-II SBPs using Clustal Omega. The 763 
resulting tree, generated using the neighbour-joining method, displays 4 main clades 764 
comprising the cluster A-II SBPs (green) and the cluster A-I SBPs subgroups associated with 765 
zinc binding (red); manganese and / or iron binding (blue); and a clade of SBPs with broad 766 
(Mn, Zn and Fe) substrate specificity (shaded purple). C. trachomatis YtgA clusters with the 767 
latter group. (b) Sequence alignment of C. trachomatis YtgA, and representative cluster A-I 768 
SBPs from the other clades. Ctr_YtgA, C. trachomatis YtgA (GI:73811687); ZnuA_Eco, E. 769 
coli ZnuA (GI:635897169); AdcA_Spn, S. pneumoniae AdcA (GI:116516060); TroA_Tpa, T. 770 
palladium (GI:504108253); TroA_Sps, S. suis (GI: 386583456); MntC_Sau, S. aureus MntC 771 
(GI:88194402); PsaA_Spn, S. pneumoniae PsaA (GI:116515973). Amino acid sequences are 772 
coloured according to the clustering in (a) with the region enriched for acidic amino acids in 773 
zinc-specific SBPs highlighted in yellow and residue numbers shown. 774 
 775 
Figure 2. Sequence comparison and secondary structure prediction of chlamydial YtgA 776 
proteins. Sequences were aligned using Clustal Omega, using full length YtgA amino acid 777 
sequences from C. trachomatis (GI:73811687), C. muridarum (GI:497916051), C. suis 778 
(GI:737424856), C. psittaci (GI:493386917), and C. pneumoniae (GI:33236198). Metal-779 
coordinating residues are coloured in red. Elements of secondary structure (red cylinder: α-780 
helix; yellow arrow: β-strand) were assigned to the sequences based on the crystal structure of 781 
C. trachomatis YtgA resolved in this study. Numbers of the amino acids are indicated at the 782 
end of each line. 783 
 784 
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Figure 3. Purification and biochemical characterisation of YtgA. (a) Determination of the 785 
apparent molecular mass of tag-free YtgA by size exclusion chromatography on a Superdex 786 
200 10/300 column. Inset is the linear regression of the protein molecular weight standards 787 
used to calibrate the column. YtgA eluted with a monomeric molecular mass of 36.2 kDa. (b) 788 
Coomassie blue-stained 12.5% SDS polyacrylamide gel showing (arrow) purified YtgA. 789 
 790 
Figure 4. DSF analyses of YtgA. Thermostability of demetallated, tag-free YtgA (dashed line) 791 
and metal-incubated (solid line) YtgA with a 10-fold concentration of the shown transition 792 
metal ion (a) Mn(II), (b) Fe(II), (c) Fe(III), (d) Co(II), (e) Ni(II), (f) Zn(II), and (g) Cd(II) or 793 
(h) a 100-fold concentration of Fe(III). Data are presented as the first derivative of the SYPRO 794 
Orange fluorescence with the inflection point value (Tm) of the solid line shown.  795 
 796 
Figure 5. Transition metal-ion interaction with YtgA. In vitro metal-binding experiments 797 
with demetallated, tag-free YtgA and transition metal ions as shown and analysed by ICP-MS. 798 
The molar ratio of metal ion-to-YtgA was determined and data correspond to mean values (± 799 
s.d.) of at least 4 independent biological experiments. Statistical significance of the differences 800 
relative to demetallated, tag-free YtgA was determined by a one-way ANOVA with Sidak post-801 
test (n.s. not significant; **** P value < 0.0001). 802 
 803 
Figure 6. Cellular metal accumulation of C. trachomatis. Total cellular metal-ion 804 
accumulation of C. trachomatis elementary bodies represented as the mean (± s.d.) 805 
concentration of ions per cell, determined as µg metal.g-1 cells (dry weight). The values are 806 
from at two independent biological experiments. Metal-ions assessed were Mn, Fe, Co, Ni, Cu, 807 
and Zn. (b.d. corresponds to ‘below detection’). 808 
 809 
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Figure 7. Crystal structure of Fe(III)-bound YtgA. (a) “Side” and (b) “top” views of the 810 
cartoon illustration of Fe-bound, tag-free YtgA in the closed conformation. The protein consists 811 
of N-terminal (green) and C-terminal (red) globular domains with a domain-linking helix 812 
(cyan). All the secondary structures are labelled with black text. The metal-binding site situates 813 
at the interface between the two domains. The bound Fe atom is shown by a black sphere and 814 
its coordinating residues are in stick representation. (c) Surface “side” view of YtgA crystal 815 
structure. The bound Fe (black sphere) is completely buried in the protein. The N-terminal, C-816 
terminal and the domain-linking helix are shown in green, red and cyan, respectively. (d) The 817 
metal-binding site of YtgA. The bound Fe (black sphere) is coordinated by three nitrogen atoms 818 
from His75, His141 and His207, respectively, and two oxygen atoms from Asp299 in a 819 
distorted trigonal bipyramidal geometry. The metal-coordinating residues are shown in stick 820 
and ball representation and the coordination bonds are represented by dashed lines. The 2Fo-Fc 821 
electron density map (blue mesh) shown is contoured at 1.5σ. 822 
 823 
Figure 8. Structural comparison of YtgA with structural homologs. (a) “Side” and (b) 824 
“top” views of structural superimposition of selected crystal structures. Green: C. trachomatis 825 
YtgA; cyan: T. pallidum TroA (PDB: 1TOA); orange: S. pneumoniae AdcAII (PDB: 3CX3); 826 
magenta: S. pyogenes MtsA (PDB: 3HH8); yellow: Y. pestis YfeA (PDB: 5UY4); light blue: 827 
S. aureus MntC (PDB: 4K3V); black: S. pneumoniae PsaA (PDB: 3ZTT). Bound metal ions 828 
are shown by spheres and their coordinating residues in stick representation. The unique α-829 
helices of YtgA are labelled. The structures were superimposed using the Cα atoms in PyMol 830 
with comparisons of the metal-binding sites to YtgA shown for: (c) Zn(II)-binding SBPs, (d) 831 
Fe-binding SBPs, and (e) Mn(II)-binding SBPs. The metal-coordinating residues are labelled 832 
based on YtgA in (c). Orientations of the view in (d) and (e) are consistent with the view in (c). 833 
 42 
Bound metal ions (spheres) and their coordinating atoms (small spheres) from the respective 834 
residues (sticks) are shown. 835 
 836 
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Figure 8 869 
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